With increasing willingness to adopt sequencing technology, the global non-invasive prenatal testing market is slated to experience a robust growth period. Fortune Business Insights shares key market information in its report, titled “Non-Invasive Prenatal Testing (NIPT) Market Size”, Share and Global Trend By Type (Products, Services), By Technique (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Others), By Application (Down Syndrome, Edwards Syndrome, Turner Syndrome, Patau Syndrome, Others), By End User (Hospitals, Diagnostic Centers, Others), and Geography Forecast till 2026”. The report also contains crucial market analysis and an in-depth assessment of the most influential factors that will shape the market in the forecast period.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998
some of the key players in the global Non-Invasive Prenatal Testing (NIPT) Market:
- LifeLabs Genetics
- Eurofins Biomnis
- Hoffmann-La Roche Ltd.
- Medgenome Claria
- Natera, Inc.
Non-invasive prenatal testing refers to sequencing procedures that help in determining the possibility of a fetus getting born with congenital or genetic abnormalities. The procedure involves testing of small fragments of DNA that freely floating around in a pregnant woman’s blood. Analyzing the free-floating DNA fragments in the placenta provides vital information that can enable early detection of genetic disorders. It is most useful in detecting chromosomal disorders that may be caused due to the presence of an extra or absence of a chromosome.
Increasing Prevalence of Genetic Disorders to Accelerate Market Growth
According to the Deciphering Developmental Disorders study, supported by UK’s National Health Service, around 300,000 infants worldwide have died due to the improper and inaccurate detection of congenital disorders such as Down Syndrome, autism, Patau Syndrome, and Edwards Syndrome. The study also reveals that prenatal genetic analysis could be the key in deciphering the causes. This information will aid in augmenting the global non-invasive prenatal testing market as new generation sequencing technologies will also help doctors in designing more accurate line of treatment that can be initiated even before the baby is born.
Improved Healthcare System to Boost the Market in Asia-Pacific; North America to be in a Leading Market Position
Rising investments in healthcare infrastructure, increasing awareness of genetic disorders, and growing preference for non-invasive tests will likely fuel the market growth in Asia-Pacific region. North America is expected to dominate the global non-invasive prenatal testing market in the forecast period as result of growing incidence of genetic anomalies, strong healthcare infrastructure, and well-established insurance system.
Major Table of Content For Non-Invasive Prenatal Testing (NIPT) Market:
- Executive Summary
- Market Dynamics
- Key Insights
- Global Non-Invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2026
- North America Non-Invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2026
- Europe Non-Invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2026
- Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2026
- Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2026
- Latin America Non-Invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2026
- Competitive Landscape
- Company Profile
New Product Launches to Make Market Competition Dynamic
New and innovate products launched by major players is expected to positively impact the global non-invasive prenatal testing market during the forecast period. For example, San Diego-based Illumina Inc. launched its VeriSeq NIPT Solution in 2017. The product would enable laboratories in Europe for in-house non-invasive prenatal testing. Such innovations will augment the global non-invasive prenatal testing market development till 2026.
Some of the key market players profiled by Fortune Business Insights include LifeLabs Genetics, Eurofins Biomnis, Hoffmann-La Roche Ltd., Medgenome Claria, Sequenom, Natera, Inc., and others.
More Trending Topics from Fortune Business Insights:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245